![Jason Fenton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jason Fenton
Directeur/Membre du Conseil chez Invea Therapeutics, Inc.
Postes actifs de Jason Fenton
Sociétés | Poste | Début | Fin |
---|---|---|---|
Invea Therapeutics, Inc.
![]() Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Directeur/Membre du Conseil | 06/12/2022 | - |
Independent Dir/Board Member | 06/12/2022 | - |
Historique de carrière de Jason Fenton
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Invea Therapeutics, Inc.
![]() Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Health Technology |
- Bourse
- Insiders
- Jason Fenton
- Expérience